Primary Record
Sapacitabine
- In stock
- 2,857 g
- Purity
- 98.4 %
- CAS
- 151823-14-2
Compound Identifiers & Properties
- CAS
- 151823-14-2
- PubChem CID
- 153970
- SMILES
- CCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)C#N
- Canonical SMILES
- CCCCCCCCCCCCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2C#N)c(=O)n1
Names & Synonyms
- Sapacitabine
- sapacitabina
- sapacitabinum
- 151823-14-2
- CS-682
- PCNDAC
- CYC682
- CNDAC cpd
- CNDAC
- CYC-682
- Sapacitabine [USAN:INN]
- CS682
- AC1L4BGC
- CYC 682
- RefChem:931256
- CS 682
- Sapacitabine (USAN/INN)
- SAPACITABINE [INN]
- D0D4RF
- SAPACITABINE [USAN]
- UNII-W335P73C3L
- Sapacitabine (CYC682)?
- W335P73C3L
- SAPACITABINE [MART.]
- SAPACITABINE [WHO-DD]
- SCHEMBL711854
- CHEBI:145429
- DTXSID90164887
- C26H42N4O5
- orb1679012
- CHEMBL2105681
- DTXCID9087378
- CS682;CYC682
- LBGFKUUHOPIEMA-PEARBKPGSA-N
- MFCD00919466
- GLXC-10703
- EX-A1617
- CID153970
- CS0045
- NSC791785
- ZINC14263648
- DB06365
- NSC-791785
- AC-36130
- HY-16445
- MS-29120
- LS-183264
- CS-0006340
- NS00071064
- J1.000.748H
- A12801
- D09722
- G12879
- Z-3189
- 823S142
- A857812
- N-(1-(2-cyano-2-deoxy-beta-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl)hexadecanamide
- 1-(2-deoxy-2-cyano-|A-d-arabinofuranosyl)cytosine
- Q7420893
- methyl N-[2-[2-(bromomethyl)phenyl]ethoxy]carbamate
- 2'-C-cyano-2'-deoxy-1-arabinofuranosyl-N(4)-palmitoylcytosine
- N-(1-((2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)palmitamide
- N-[1-[(2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]hexadecanamide
- 1-(2-c-cyano-2-deoxy-|A-d-arabino-pentofuranosyl)cytosine
- Hexadecanamide, N-(1-(2-cyano-2-deoxy-beta-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl)-
- N-[1-(2-cyano-2-deoxy-beta-D-arabinofuranosyl)-2-oxo-1,2-dihydropyrimidine-4-yl]hexadecanamide
- N-Palmitoyl-1-(2-cyano-2-deoxy-beta-D-arabino-pentofuranosyl)cytosine
- 1-(2-cyano-2-deoxy-beta-D-arabinofuranosyl)-4-(hexadecanoylamino)pyrimidin-2(1H)-one
- 1-(2-Cyano-2-deoxy-beta-D-arabinofuranosyl)-4-hexadecanamidopyrimidin-2(1H)-one
- 1-(2-cyano-2-deoxy-|A-d-arabinofuranosyl)-4-(palmitoylamino)pyrimidin-2(1h)-one,sapacitabine
- 151827-86-0
- 4-amino-1-[(3|A-cyano-4|A-hydroxy-5|A-hydroxymethyltetrahydrofuran)-2|A-yl]pyrimidin-2(1h)-one
- HEXADECANAMIDE, N-(1-(2-CYANO-2-DEOXY-.BETA.-D-ARABINOFURANOSYL)-1,2-DIHYDRO-2-OXO-4- PYRIMIDINYL)-
- N-(1-((2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)hexadecanamide
- N-(1-(2-CYANO-2-DEOXY-.BETA.-D-ARABINOFURANOSYL)-2-OXO-1,2-DIHYDROPYRIMIDIN-4- YL)HEXADECANAMIDE
- N-(1-(2-Cyano-2-deoxy-beta-D-arabinofuranosyl)-2-oxo-1,2-dihydropyrimidin-4-yl)-hexadecanamide
- N-[1-(2-C-Cyano-2-deoxy-beta-D-arabinofuranosyl)-2-oxo-1,2-dihydropyrimidine-4-yl]hexadecanamide
- N-[1-(2-Cyano-2-deoxy-|_-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl]hexadecanamide
- N-[1-(2-Cyano-2-deoxy-ss-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl]hexadecanamide; CS 682; CS 682
- N-[1-[(2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-2-oxo-pyrimidin-4-yl]hexadecanamide
- N-{1-[(2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-1,2-dihydropyrimidin-4-yl}hexadecanamide